anti-MUC1 antibodies (Cancer Research Technology/Copenhagen University)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-MUC1 antibodies (Cancer Research Technology/Copenhagen University)
Drug Alias Name2-D-95-E-5
ClassificationDiagnostic agent (In vivo)Biologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionMucin-1 modulators
TargetsMucin-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Copenhagen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A